SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
NYSE New York Stock Exchange
Börse NYSE New York Stock Exchange
ISIN US7170811035
USD
  • Pfizer
    Börse NYSE New York Stock Exchange
    ISIN US7170811035 WKN: 852009
    Symbol PFE
    USD
  • Pfizer
    Börse Börse Stuttgart
    ISIN US717081DK61
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081ER06
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Hamburg
    ISIN US717081ED10
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Düsseldorf
    ISIN XS1574158082
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse München
    ISIN US717081DZ31
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Gettex System der Börse München
    ISIN US717081ES88
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    ISIN US717081EQ23
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Quotrix System der Börse Düsseldorf
    ISIN US717081DE02
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Frankfurt
    ISIN XS1574157357
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081EY56
    EUR
  • Pfizer
    Börse Börse München
    ISIN US717081FA61
    EUR
  • Pfizer
    Börse SSE Stockholm Stock Exchange
    ISIN US717081EZ22
    Symbol PFE
    SEK
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081EK52
    Symbol PFE
    MXN
  • Pfizer
    Börse Bolsa de Comercio de Buenos Aires
    ISIN US717081DV27
    USD
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081DH33
    MXN
  • Pfizer
    Börse BUE
    ISIN US717081EV18
    USD
  • ISIN US717081EX73
    Symbol PFE
    EUR
  • Pfizer
    Börse OMXS
    ISIN US7170811035
    SEK
  • ISIN US717081EJ89
    EUR
  • PFIZER INC
    Börse SSE
    ISIN US717081EP40
ISIN US7170811035
WKN 852009
Symbol PFE
Währung USD
Börse NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Firmenname Pfizer Inc
Marktkapitalisierung 197.500.079.920 (+- 10%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

204.882.624.512 oder 216.419.000.000 oder 171.198.615.249

Mitarbeiter 83.400 (+- 6%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

88.300 oder 78.500 Mitarbeiter

Anzahl Aktien 5.558.396.599
KGV 18.68 (+- 28%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

23.97 oder 13.4

EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744

Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht

Die Dividendenrendite entsprach 4,02 % p. a. beim aktuellen Kurs von 36,59 USD -0,04% 

Pfizer underperformed den DAX um -10 % (+35 % Dividenden) vom 07.10.2013 bis 14.09.2021

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 36,59 USD -0,04% 

Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat Pfizer abonniert.

Aktionärsstruktur der Pfizer Inc

941 News & Informationen zur Pfizer Aktie

  • Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
    globenewswire.com

    Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030

    The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…

  • Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
    globenewswire.com

    Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030

    The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…

  • Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
    globenewswire.com

    Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030

    The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…

  • Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
    globenewswire.com

    Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030

    The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…

  • This Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine
    fool.com

    This Could Be Pfizer's Next COVID Blockbuster — and It Isn't a Vaccine

    Pfizer might not have to wait very long for this product to hit the market.

  • U.S. Says It Has Shared 110 Million Covid-19 Vaccine Doses Overseas
    online.wsj.com

    U.S. Says It Has Shared 110 Million Covid-19 Vaccine Doses Overseas

    The Biden administration fell short of its initial goal of shipping 80 million doses by the end of June.

  • Sanofi Snaps Up mRNA Specialist for $3.2 Billion Amid Vaccine Success
    online.wsj.com

    Sanofi Snaps Up mRNA Specialist for $3.2 Billion Amid Vaccine Success

    French healthcare company Sanofi agreed to acquire Translate Bio, a big vote of confidence that the new technology underpinning two successful Covid-19 vaccines holds promise beyond the pandemic.

  • European Stocks Mixed; Societe Generale, BP Impress With Earnings By Investing.com
    investing.com

    European Stocks Mixed; Societe Generale, BP Impress With Earnings By Investing.com

    European Stocks Mixed; Societe Generale, BP Impress With Earnings

  • Analysis: Tougher terms: why the EU is paying more for new COVID shots By Reuters
    investing.com

    Analysis: Tougher terms: why the EU is paying more for new COVID shots By Reuters

    Analysis: Tougher terms: why the EU is paying more for new COVID shots

  • Sydney COVID lockdown could be eased if vaccination rate hits 50% By Reuters
    investing.com

    Sydney COVID lockdown could be eased if vaccination rate hits 50% By Reuters

    Sydney COVID lockdown could be eased if vaccination rate hits 50%

  • Top Research Reports for Amazon, Pfizer & Verizon
    zacks.com

    Top Research Reports for Amazon, Pfizer & Verizon

    Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Pfizer Inc. (PFE), and Verizon Communications Inc. (VZ).

  • Pfizer and Moderna raise prices for COVID-19 vaccines in EU- FT
    financialpost.com

    Pfizer and Moderna raise prices for COVID-19 vaccines in EU- FT

    Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported…

  • Videogames entered the mainstream in the pandemic, but the industry faces a rough transition
    marketwatch.com

    Videogames entered the mainstream in the pandemic, but the industry faces a rough transition

    For decades, Wall Street has viewed videogames like most Americans: A fun little diversion from everyday life, but not something to take too seriously. But…

  • FDA May Grant Full Approval For Pfizer Jab As Early As September
    zerohedge.com

    FDA May Grant Full Approval For Pfizer Jab As Early As September

    ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero

  • Barron's Latest Picks And Pans: American Express, GE, GlaxoSmithKline, Intel And More
    markets.businessinsider.com

    Barron's Latest Picks And Pans: American Express, GE, GlaxoSmithKline, Intel And More

    This weekend's Barron's offers investors an overlooked way to play the coming infrastructure surge. Other featured articles discuss how t…

  • U.S. administers 346.5 million doses of COVID-19 vaccines -CDC By Reuters
    investing.com

    U.S. administers 346.5 million doses of COVID-19 vaccines -CDC By Reuters

    U.S. administers 346.5 million doses of COVID-19 vaccines -CDC

  • Can Merck Beat Pfizer in This Multibillion-Dollar Vaccine Market?
    fool.com

  • Investing in These Stocks Now Could Make You a Millionaire Retiree
    fool.com

    Investing in These Stocks Now Could Make You a Millionaire Retiree

    It doesn't take much money — or a lot of time, really — to make $1 million.

  • Pfizer and Moderna raise prices for its COVID-19 vaccines in EU- FT By Reuters
    investing.com

    Pfizer and Moderna raise prices for its COVID-19 vaccines in EU- FT By Reuters

    Pfizer and Moderna raise prices for its COVID-19 vaccines in EU- FT

  • 8 Reasons to Love Monthly Dividend ETFs
    investopedia.com

    8 Reasons to Love Monthly Dividend ETFs

    A review of eight exchange-traded funds (ETFs) that offer investors monthly dividends.

  • U.S. administers 345.6 million doses of COVID-19 vaccines
    investing.com

    U.S. administers 345.6 million doses of COVID-19 vaccines

    U.S. administers 345.6 million doses of COVID-19 vaccines – CDC

  • Amid the Rise of the Delta Variant, Here's My Top Coronavirus Vaccine Stock to Buy
    fool.com

    Amid the Rise of the Delta Variant, Here's My Top Coronavirus Vaccine Stock to Buy

    Hint: You may have heard a lot about this company in the past year.

  • What Would Full FDA Approval of Pfizer's COVID Vaccine Mean for the Stock?
    fool.com

  • Claudia M.p. Batlle, Crp (r) Llc Buys Starbucks Corp, Pfizer Inc, Dow Inc, Sells Oracle Corp, NextEra Energy Inc, Thermo Fisher Scientific...
    gurufocus.com

    Claudia M.p. Batlle, Crp (r) Llc Buys Starbucks Corp, Pfizer Inc, Dow Inc, Sells Oracle Corp, NextEra Energy Inc, Thermo Fisher Scientific Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Insights on the Targeted Therapeutics Global Market to 2031 - Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
    prnewswire.com

    Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others

    /PRNewswire/ — The “Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031” report has been added to…

  • Insights on the Targeted Therapeutics Global Market to 2031 - Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
    markets.businessinsider.com

    Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others

    DUBLIN, July 30, 2021 /PRNewswire/ — The 'Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 202…

  • Most COVID-19 cases in Massachusetts outbreak among vaccinated, says CDC
    financialpost.com

    Most COVID-19 cases in Massachusetts outbreak among vaccinated, says CDC

    Three-quarters of people infected with COVID-19 at July public events in a town on Cape Cod in Massachusetts were fully vaccinated, a study by the U.S. Centers…

  • CDC data shows that 74% of people who tested positive for the virus in Massachusetts outbreak were fully vaccinated
    marketwatch.com

    CDC data shows that 74% of people who tested positive for the virus in Massachusetts outbreak were fully vaccinated

    A federal investigation into a COVID-19 outbreak earlier this month in a part of Massachusetts that is home to Cape Cod and Provincetown found that 74% of…

  • 15 Most Valuable Biotech Companies in the World
    insidermonkey.com

    15 Most Valuable Biotech Companies in the World

    In this article we will take a look at the 15 most valuable biotech companies in the world. You can skip our detailed analysis of the biotechnology industry…

  • Is Viatris a Winner in the Pharmaceuticals Industry? By StockNews
    investing.com

    Is Viatris a Winner in the Pharmaceuticals Industry? By StockNews

    Is Viatris a Winner in the Pharmaceuticals Industry?

  • Have $500? Here Are 2 High-Yielding Healthcare Stocks to Consider
    fool.com

    Have $500? Here Are 2 High-Yielding Healthcare Stocks to Consider

    These two companies offer impressive — and safe — yields for investors who like income.

  • Friday Morning Reads
    optionmillionaires.com

  • Elon Musk, Jeff Bezos & Richard Branson: Which Market Leaders Will Make Up The Cannabis Industry Space Race?
    markets.businessinsider.com

    Elon Musk, Jeff Bezos & Richard Branson: Which Market Leaders Will Make Up The Cannabis Industry Space Race?

    As billionaires like Elon Musk, Jeff Bezos and Richard Branson race for space, who will be the leaders in the nascent cannabis industry as it vaul…

  • Elon Musk, Jeff Bezos & Richard Branson: Which Market Leaders Will Make Up The Cannabis Industry Space Race?
    news.google.com

    Elon Musk, Jeff Bezos & Richard Branson: Which Market Leaders Will Make Up The Cannabis Industry Space Race?

    As billionaires like

  • Smoking Cessation and Nicotine De-Addiction Market to grow by USD 16.6 billion | Technavio
    prnewswire.com

    Smoking Cessation and Nicotine De-Addiction Market to grow by USD 16.6 billion | Technavio

    /PRNewswire/ — As per Technavio's Research Analysis, the smoking cessation and nicotine de-addiction market is likely to register a CAGR of over 13% while…

  • Why BioNTech Stock Jumped This Week
    fool.com

  • This 1 Thing in Pfizer's Earnings Report May be a Coronavirus Game Changer
    fool.com

    This 1 Thing in Pfizer's Earnings Report May be a Coronavirus Game Changer

    Pfizer is ready to take on a second coronavirus market.

  • North Asia Catches A Friday Flu
    investing.com

    North Asia Catches A Friday Flu

    Market Overview Analysis by MarketPulse (Jeffrey Halley) covering: Pfizer Inc, US Dollar Index Futures. Read MarketPulse (Jeffrey Halley)'s latest article on Investing.com

  • Oak Family Advisors, Llc Buys Northrop Grumman Corp, Vanguard Short-Term Inflation-Protected Securities, B2Gold Corp, Sells Weyerhaeuser...
    gurufocus.com

    Oak Family Advisors, Llc Buys Northrop Grumman Corp, Vanguard Short-Term Inflation-Protected Securities, B2Gold Corp, Sells Weyerhaeuser Co, Dominion Energy Inc, Pfizer Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Israel to Offer Pfizer Booster Shots to Elderly as Delta Cases Rise
    online.wsj.com

    Israel to Offer Pfizer Booster Shots to Elderly as Delta Cases Rise

    The move to authorize a booster shot for people 60 and over came after early data in Israel suggested vaccine protection against severe illness has waned.

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Pfizer Aktie

Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.

Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.

Die Pfizer Aktie hat inklusive der Dividendenausschüttungen seit dem 07.10.2013 eine Gesamtrendite von 108% erwirtschaftet

Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba